|
1
|
Hollan I, Meroni PL, Ahearn JM, Cohen
Tervaert JW, Curran S, Goodyear CS, Hestad KA, Kahaleh B, Riggio M,
Shields K, et al: Cardiovascular disease in autoimmune rheumatic
diseases. Autoimmun Rev. 12:1004–1015. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nikpour M, Urowitz MB, Ibañez D and
Gladman DD: Frequency and determinants of flare and persistently
active disease in systemic lupus erythematosus. Arthritis Rheum.
61:1152–1158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gaggin HK and Januzzi JL Jr: Natriuretic
peptides in heart failure and acute coronary syndrome. Clin Lab
Med. 34:43–58. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gaggin HK and Januzzi JL Jr: Biomarkers
and diagnostics in heart failure. Biochim Biophys Acta.
1832:2442–2450. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hochberg MC: Updating the American College
of Rheumatology revised criteria for the classification of systemic
lupus erythematosus. Arthritis Rheum. 40:17251997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bombardier C, Gladman DD, Urowitz MB,
Caron D, Chang CH, Austin A, Bell A, Bloch DA, Corey PN, Decker JL,
et al: The Committee on Prognosis Studies in SLE: Derivation of the
SLEDAI. A disease activity index for lupus patients. Arthritis
Rheum. 35:630–640. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ye Y, Wang Y and Shen Z: National Guide to
Clinical Laboratory Procedures of China. (3rd). Medical
Administration Department of Ministry of Public Health (China).
2006.
|
|
8
|
Aranow C and Ginzler EM: Epidemiology of
cardiovascular disease in systemic lupus erythematosus. Lupus.
9:166–169. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Manzi S, Selzer F, Sutton-Tyrrell K,
Fitzgerald SG, Rairie JE, Tracy RP and Kuller LH: Prevalence and
risk factors of carotid plaque in women with systemic lupus
erythematosus. Arthritis Rheum. 42:51–60. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ammirati E, Moroni F, Pedrotti P, Scotti
I, Magnoni M, Bozzolo EP, Rimoldi OE and Camici PG: Non-invasive
imaging of vascular inflammation. Front Immunol. 5:3992014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bruce IN, Gladman DD and Urowitz MB:
Premature atherosclerosis in systemic lupus erythematosus. Rheum
Dis Clin North Am. 26:257–278. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Esdaile JM, Abrahamowicz M, Grodzicky T,
Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR,
Clarke AE, et al: Traditional Framingham risk factors fail to fully
account for accelerated atherosclerosis in systemic lupus
erythematosus. Arthritis Rheum. 44:2331–2337. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ronda N, Favari E, Borghi MO, Ingegnoli F,
Gerosa M, Chighizola C, Zimetti F, Adorni MP, Bernini F and Meroni
PL: Impaired serum cholesterol efflux capacity in rheumatoid
arthritis and systemic lupus erythematosus. Ann Rheum Dis.
73:609–615. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Symmons DP and Gabriel SE: Epidemiology of
CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev
Rheumatol. 7:399–408. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hunt PJ, Richards AM, Nicholls MG, Yandle
TG, Doughty RN and Espiner EA: Immunoreactive amino-terminal
pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac
impairment. Clin Endocrinol (Oxf). 47:287–296. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ardoin SP, Schanberg LE, Sandborg C, Yow
E, Barnhart HX, Mieszkalski K, Ilowite NT, von Scheven E, Eberhard
A, Levy DM, et al: APPLE investigators: Laboratory markers of
cardiovascular risk in pediatric SLE: The APPLE baseline cohort.
Lupus. 19:1315–1325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soep JB, Mietus-Snyder M, Malloy MJ,
Witztum JL and von Scheven E: Assessment of atherosclerotic risk
factors and endothelial function in children and young adults with
pediatric-onset systemic lupus erythematosus. Arthritis Rheum.
51:451–457. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Posadas-Romero C, Torres-Tamayo M,
Zamora-González J, Aguilar-Herrera BE, Posadas-Sánchez R,
Cardoso-Saldaña G, de Guevara Ladrón G, Solis-Vallejo E and El
Hafidi M: High insulin levels and increased low-density lipoprotein
oxidizability in pediatric patients with systemic lupus
erythematosus. Arthritis Rheum. 50:160–165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lilleby V, Haugen M, Mørkrid L, Frey
Frøslie K, Holven KB and Førre O: Body composition, lipid and
lipoprotein levels in childhood-onset systemic lupus erythematosus.
Scand J Rheumatol. 36:40–47. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tyrrell PN, Beyene J, Benseler SM,
Sarkissian T and Silverman ED: Predictors of lipid abnormalities in
children with new-onset systemic lupus erythematosus. J Rheumatol.
34:2112–2119. 2007.PubMed/NCBI
|
|
21
|
Borba EF and Bonfá E: Dyslipoproteinemias
in systemic lupus erythematosus: Influence of disease, activity,
and anticardiolipin antibodies. Lupus. 6:533–539. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stampfer MJ, Krauss RM, Ma J, Blanche PJ,
Holl LG, Sacks FM and Hennekens CH: A prospective study of
triglyceride level, low-density lipoprotein particle diameter, and
risk of myocardial infarction. JAMA. 276:882–888. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ilowite NT, Samuel P, Ginzler E and
Jacobson MS: Dyslipoproteinemia in pediatric systemic lupus
erythematosus. Arthritis Rheum. 31:859–863. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Beaumont JL and Beaumont V: Autoimmune
hyperlipidemia. Atherosclerosis. 26:405–418. 1977. View Article : Google Scholar : PubMed/NCBI
|
